1. Thromboembolism: an under appreciated cause of death [editorial]. Lancet Haematol 2015; 2(10): e393, doi: 10.1016/S2352-3026(15)00202-1.
2.
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126(Suppl): 338–400, doi: 10.1378/chest.126.3_suppl.338S.
3.
Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016; 118(9): 1340–1347, doi: 10.1161/CIRCRESAHA.115.306841.
4.
Dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest 2002; 122(4): 1440–1456, doi: 10.1378/chest.122.4.1440.
5.
Pop C, Ferent I. High D-Dimer Values and Post-Discharge Acute Pulmonary Embolism in Young Patients with COVID-19: A Case Series. Sanamed 2021; 16(1): 85–90.
6.
Gerotziafas GT, Catalano M, Colgan M, et al. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost 2020; 120(12): 1597–1628, doi: 10.1055/s-0040-1715798.
7.
Kumar A, Narayan RK, Prasoon P, et al. COVID-19 Mechanisms in the Human Body-What We Know So Far. Front Immunol 2021; 12: 693938, doi: 10.3389/fimmu.2021.693938.
8.
Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 2020; 50(1): 54–67.
9.
Rahban M, Stanek A, Hooshmand A, et al. Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. J Clin Med 2021; 10(21): 4802.
10.
Ribeiro DD, Lijfering WM, Vlieg AVH, et al. Pneumonia and risk of venous thrombosis: results from the MEGA study. J Thromb Haemost 2012; 10(6): doi: 1179-1182, 10.1111/j.1538–7836.2012.04732.x.
11.
Smeeth L, Cook C, Thomas S, et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367(9516): 1075–1079, doi: 10.1016/S0140-6736(06)68474–2.
12.
Dam LF van, Kroft LJM, Wal LI van der, et al. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: a different phenotype of thrombotic disease? Thromb Res 2020; 193: 86–89.
13.
Desai R, Gandhi Z, Singh S, et al. Prevalence of pulmonary embolism in COVID-19: a pooled analysis. SN Compr Clin Med 2020: 1–4, doi: 10.1007/s42399-020-00605-5.
14.
Vlachou M, Drebes A, Candilio L, et al. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J Thromb Thrombolysis 2021; 51(4): 978–984.
15.
Silva BV, Rodrigues T, Cunha N, et al. Pulmonary embolism during the COVID-19 pandemic. Eur J Prev Cardiol 2021; 28(1): zwab061.183, doi: 10.1093/eurjpc/zwab061.183.
16.
İlhan E, Oztop M, Ureyen O, et al. Evaluatıon of the effect of Covıd-19 pandemıc on emergency and electıve surgıcal interventıons in general surgery clınıc: a cross-sectıonal study. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 2020; 53(3): 202–205.
17.
Kılıç B, Gülabi D, Agar A, et al. How did restrictions mandated by the COVID-19 pandemic affect the performance of orthopedic trauma surgery in a Level-1 tertiary trauma hospital? Ulus Travma Acil Cerrahi Derg 2021; 27(5): 547–551.
18.
Karataş MB, İpek G, Onuk T, et al. Assessment of prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with pulmonary embolism. Acta Cardiol Sin 2016; 32: 313–320.
19.
Wang Q, Ma J, Jiang Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol 2018; 37: 4–11.
20.
Kasapoğlu US, Yıldızeli ŞO, Arıkan H, et al. Comparison of neutrophil to lymphocyte ratio with other prognostic markers affecting 30 day mortality in acute pulmonary embolism. Tuberk Toraks 2019; 67(3): 179–189.
21.
Erjilany I, Elzouki AN. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review. Vasc Health Risk Manag 2020; 16: 455–462, doi: 10.2147/VHRM.S280962.
